Progenika Biopharma, S.A.

Progenika Biopharma S.A. is a privately owned Spanish company founded in April 2000, with the aim of designing and developing tools for Personalized Medicine.

The company develops and manufactures novel DNAchips for Genotyping that can be used in the diagnosis and prognosis of human diseases.

More than 60 scientists work at Progenika, whose state of the art facilities are situated in the Bizkaia Technology Park in the outskirts of Bilbao (Spain). Progenika’s fully equipped installations are specifically designed for the production and analysis of DNAchips. This state of the art equipment is backed up by a team of Computer experts who develop the algorithms and software that facilitate the automatic interpretation of DNAchip results.

Proteomika S.L., a subsidiary of Progenika that provides complementary skills in protein biomarker detection. Proteomika is involved in the development of protein arrays for the detection of disease biomarkers in human fluids.